Recommendations for the Treatment of Rheumatoid Arthritis. Results from a German Consensus Conferenence: Update 2009;Aktualisiertes Therapieschema der Rheumatoiden Arthritis. Ergebnisse eines Konsensusprozesses deutscher Rheumatologen 2009:

Aktuelle Rheumatologie

Volumn 34, Issue 4, 2009, Pages 234-239

  Wollenhaupt, J ^a   Alten, R ^b   Backhaus, M ^b   Baerwald, C ^c   Braun, J ^d   Burkhardt, H ^e   Gaubitz, M ^f   Gromnicaihle, E ^g   Kellner, H ^h   Kuipers, J ⁱ   H M Lorenz, ^j   Manger, B ^k   U Muller Ladner ^l   Nusslein H G ^m   H G Pott, ⁿ   A Rubbert Roth, ^o   Schneider, M ^p   Specker, C ^q   H P Tony, ^r   Kruger K ^s  

^a Abteilung Rheumatologie und Klinische Immunologie   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d RHEUMAZENTRUM RUHRGEBIET   (Germany)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g MARTIN LUTHER KRANKENHAUS   (Germany)

^h Krankenhaus Neuwittelsbach   (Germany)

ⁱ Rotes Kreuz Krankenhaus Bremen   (Germany)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^l JUSTUS LIEBIG UNIVERSITY   (Germany)

^m Internistisch rheumatologische Schwerpunktpraxis   (Germany)

ⁿ Rheumatologikum Hannover   (Germany)

^o UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^p HEINRICH HEINE UNIVERSITY   (Germany)

^q Katholisches Krankenhaus St Josef GmbH   (Belgium)

^r UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^s Praxiszentrum   (Germany)

more..

Author keywords

Biologicals; Consensus; Recommendations; Rheumatoid arthritis; Therapy

Indexed keywords

ABATACEPT; ADALIMUMAB; ATLIZUMAB; AZATHIOPRINE; CERTOLIZUMAB PEGOL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; GOLIMUMAB; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE;

CELL STIMULATION; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DRUG RESPONSE; HUMAN; JOINT RADIOGRAPHY; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; REMISSION; RHEUMATOID ARTHRITIS; SYNOVITIS;

EID: 70349411813     PISSN: 0341051X     EISSN: 14389940     Source Type: Journal    
DOI: 10.1055/s-0029-1220906     Document Type: Conference Paper

References (23)

1. Boers M, Verhoeven AC, van der Linden S. Combination therapy in early rheumatoid arthritis: the COBRA study. Med Tidschr Geneeskd 1997; 141:2428-2432
2. Breedveld F, Weisman M, Kavanaugh A. The Premier study. A multicenter randomized double-blind trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adali-mumab alone in patients with early, aggressive rheumatoid arthritis who had not previos methotrexate treatment. Arthritis Rheum 2006; 54:26-37
3. Buch MH, Binham SJ, Bejarano V et al. Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched of etanercept. Arthritis Rheum 2007 ; 57 : 448-453
4. Cohen G, Courvoisier N, Cohen JD et al. The efficiency of switching from Infliximab to Etanercept and vice-versa in patients with rheumatoid arthritis. Clin Exp Rheumatolo 2005; 23: 795-800
5. Cohen SB, Emery P, Greenwald MW et al. Rituximab for rheumatoid arthritis refractory to antitumor necrosis factor therapy: results of a multicenter, randomized double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks . Arthritis Rheum 2006 ; 54 : 2793-2806
6. Donahue KE, Gartlehner G, Jonas DE et al. Systemic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med 2008; 148: 124-134
7. Durez P, Malghem J, Toukap AN. A randomized magnetic resonance imaging study comparing the effects of methotrexate alone in combination with Infliximab, an Methotrexat in combination with IV methylprednisolone. Arthritis Rheum 2007 ; 56 : 3919-3927
8. Emery P, Breedveld FC, Hall S et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 2008; 372 (9636) : 375-382
9. Genovese MC, Bathon JM, Martin RW. Etanercept versus methotrexate in patients with early rheumatoid arthritis. Two-year radiographic and clinical outcomes. Arthritis Rheum 2002; 46: 1143-1450
10. Genovese MC, Schiff M, Luggen M et al. Efficacy and safety of the selective co-stimulation modulator Abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-TNF-therapy. Ann Rheum dis 2007, [Epub ahead of print]
11. Goekoop-Ruiterman YP, de Vries-Bowstra JK, Allaart CF et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeST study): a randomized controlled trial. Arthritis Rheum 2005; 52: 3381-3390
12. Grigor C, Capell H, Stirling A et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a singleblind randomized controlled trial. Lancet 2004 ; 364 : 263-269
13. Finckh A, Ciurea A, Brulhart L et al.B cell depletion may be more effective than switching to an alternative antitumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to antitumor necrosis factor agents. Arthritis Rheum 2007; 56: 1417-1423
14. Finck A, Liang MH, van Heckenrode CM et al. Long-termin impact of early treatment on radiographic progression in rheumatoid arthritis: a metaanalysis . Arthritis Rheum 2006 ; 55 : 864-872
15. Kirwan JR, Bijlsma JW, Boers M et al. Effects of glucocorticoids on radiographic progression in rheumatoid arthritis. Cochrane Database Syst Rev 2007; 1: CD006356
16. M öttö nen T, Hannonen P, Leirisalo-Repo M et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomized trial. FIN-RACo trial group. Lancet 1999; 353: 1568-1573 (Pubitemid 29219206)
17. Smolen JS, van der Heijde DMFM, St. Clair W. Predictors of joint damage in patients with aerly rheumatoid arthritis treatet with high-dose methotrexate with or without concomitant Infliximab. Results from the ASPIRE trial . Arthritis Rheum 2006 ; 54 : 702-710
18. St. Clair WE, van der Heijde DMFM, Smolen JS. Combination of Infliximab and methotrexate therapy for early rheumatoid arthritis. Arthritis Rheum 2004 ; 50 : 3432-3443
19. van der Helm-van Mil AH, le Cessie S, van Dongen H et al. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 2007 ; 56 : 433-440
20. van Dongen H, van Aken J, Lard LR et al. Efficacy of methotrexate in patients with probable rheumatoid arthritis: a double-blind randomized placebo-controlled trial. Arthritis Rheum 2007; 56: 1424-1432
21. van der Kooij sM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP et al. Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to he disease activity score. Ann Rheum Dis 2007; 66: 1356-11352
22. Wick MC, Ernestan S, Lindblad S et al. Adalimumab (Humira) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade) or Etanercept (Enbrel): results from the STURE registry at Karolinska University Hospital. Scand J Rheumatol 2005;34 : 353-358
23. Wollenhaupt J, Alten R, Burckhardt H et al. Aktuelle Therapiestrategien bei rheumatoider Arthritis. Entzündung rasch beherrschen ist entscheidend für die Prognose. MMW Fortschritte der Medizin 2007;148 : 38-42.